Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Cellular models and therapies for age-related macular degeneration.

Forest DL, Johnson LV, Clegg DO.

Dis Model Mech. 2015 May;8(5):421-7. doi: 10.1242/dmm.017236. Review.

2.

New compstatin peptides containing N-terminal extensions and non-natural amino acids exhibit potent complement inhibition and improved solubility characteristics.

Gorham RD Jr, Forest DL, Khoury GA, Smadbeck J, Beecher CN, Healy ED, Tamamis P, Archontis G, Larive CK, Floudas CA, Radeke MJ, Johnson LV, Morikis D.

J Med Chem. 2015 Jan 22;58(2):814-26. doi: 10.1021/jm501345y. Epub 2014 Dec 29.

3.

Novel compstatin family peptides inhibit complement activation by drusen-like deposits in human retinal pigmented epithelial cell cultures.

Gorham RD Jr, Forest DL, Tamamis P, López de Victoria A, Kraszni M, Kieslich CA, Banna CD, Bellows-Peterson ML, Larive CK, Floudas CA, Archontis G, Johnson LV, Morikis D.

Exp Eye Res. 2013 Nov;116:96-108. doi: 10.1016/j.exer.2013.07.023. Epub 2013 Aug 15.

4.

Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration.

Johnson LV, Forest DL, Banna CD, Radeke CM, Maloney MA, Hu J, Spencer CN, Walker AM, Tsie MS, Bok D, Radeke MJ, Anderson DH.

Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18277-82. doi: 10.1073/pnas.1109703108. Epub 2011 Oct 3.

6.

Aflatoxin levels in corn available as wild turkey feed in Georgia.

Schweitzer SH, Ouist CF, Grimes GL, Forest DL.

J Wildl Dis. 2001 Jul;37(3):657-9.

PMID:
11504246

Supplemental Content

Loading ...
Support Center